Fig. 3From: The cost-effectiveness of B-type natriuretic peptide-guided care in compared to standard clinical assessment in outpatients with heart failure in Tehran, IranThe results of the probabilistic sensitivity analysis. Each point indicates the differences in the costs and effectiveness of BNP vs. standard clinical assessment. The results showed that BNP was more cost-effective than standard clinical assessment with a maximum willingness to pay threshold of USD20800Back to article page